• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials.

作者信息

Ottaiano Alessandro, Santorsola Mariachiara, Caracò Federica, Caraglia Michele, Nasti Guglielmo

机构信息

Deparment of Abdominal Oncology, SSD-Innovative Therapies for Abdominal Cancers, Istituto Nazionale Tumori IRCCS "Fondazione G Pascale", Naples 80131, Italy.

Deparment of Abdominal Oncology, SSD-Innovative Therapies for Abdominal Cancers, Istituto Nazionale Tumori IRCCS "Fondazione G Pascale", Naples 80131, Italy.

出版信息

Lancet Oncol. 2022 Apr;23(4):452-454. doi: 10.1016/S1470-2045(22)00034-1.

DOI:10.1016/S1470-2045(22)00034-1
PMID:35358452
Abstract
摘要

相似文献

1
Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials.3期临床试验中的初始肿瘤负荷与隐匿性寡转移疾病
Lancet Oncol. 2022 Apr;23(4):452-454. doi: 10.1016/S1470-2045(22)00034-1.
2
The impact of local and regional disease extent on overall survival in patients with advanced stage IIIB/IV non-small cell lung carcinoma.局部和区域疾病范围对晚期 IIIB/IV 期非小细胞肺癌患者总生存的影响。
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e385-92. doi: 10.1016/j.ijrobp.2012.04.045. Epub 2012 Aug 1.
3
[Proton therapy in advanced lung cancer, a clinical phase III trial].[晚期肺癌的质子治疗，一项III期临床试验]
Bull Cancer. 2018 Jul-Aug;105(7-8):634-635. doi: 10.1016/j.bulcan.2018.04.010. Epub 2018 Jun 7.
4
Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation.肿瘤大小测量中操作者间变异性对基于模型的药物效应评估的影响。
Cancer Chemother Pharmacol. 2020 Apr;85(4):817-825. doi: 10.1007/s00280-020-04049-5. Epub 2020 Mar 13.
5
[New TNM classification of non-small cell lung cancer].[非小细胞肺癌的新TNM分类]
Rev Pneumol Clin. 2017 Feb;73(1):34-39. doi: 10.1016/j.pneumo.2016.12.006. Epub 2017 Feb 6.
6
Adjuvant chemotherapy in non-small cell lung cancer (NSCLC).非小细胞肺癌的辅助化疗
Ann Oncol. 2007 Jul;18 Suppl 9:ix143-6. doi: 10.1093/annonc/mdm309.
7
Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?寡转移非小细胞肺癌的根治性治疗：时机已到？
Eur J Cancer. 2017 Jul;79:149-151. doi: 10.1016/j.ejca.2017.04.008. Epub 2017 May 8.
8
[Current trends in the treatment of locally advanced non-small cell bronchopulmonary carcinoma].[局部晚期非小细胞支气管肺癌的当前治疗趋势]
Arch Bronconeumol. 2001 Nov;37(10):435-43. doi: 10.1016/s0300-2896(01)75114-9.
9
[Stereotaxic ablative radiotherapy in stage 1 non-small-cell lung cancer: Results of the phase 3 randomized trial "CHISEL"].[立体定向消融放疗用于Ⅰ期非小细胞肺癌：Ⅲ期随机试验“CHISEL”的结果]
Bull Cancer. 2020 Feb;107(2):145-147. doi: 10.1016/j.bulcan.2019.11.001. Epub 2020 Feb 5.
10
Second-line chemotherapy for non-small cell lung cancer.非小细胞肺癌的二线化疗
Chest. 2006 Apr;129(4):840-2. doi: 10.1378/chest.129.4.840.

引用本文的文献

1
Patterns of metastatic spread and tumor burden in unselected cancer patients using PET imaging: Implications for the oligometastatic spectrum theory.利用PET成像研究未选择的癌症患者的转移扩散模式和肿瘤负荷：对寡转移谱理论的启示。
Clin Transl Radiat Oncol. 2024 Jan 9;45:100724. doi: 10.1016/j.ctro.2024.100724. eCollection 2024 Mar.
2
Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.寡转移型胃肠道新生肿瘤：临床和分子驱动因素的鉴定：PREDICTION 研究。
BMC Cancer. 2023 Oct 19;23(1):1010. doi: 10.1186/s12885-023-11479-w.
3
Mathematical prediction with pretreatment growth rate of metastatic cancer on outcomes: implications for the characterization of oligometastatic disease.
基于转移性癌症治疗前生长速率对预后进行数学预测：对寡转移疾病特征的意义
Front Oncol. 2023 May 29;13:1061881. doi: 10.3389/fonc.2023.1061881. eCollection 2023.
4
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review.转移性肺癌、乳腺癌和结直肠癌 III 期临床试验中的肿瘤负荷报告：一项系统综述
Cancers (Basel). 2022 Jul 3;14(13):3262. doi: 10.3390/cancers14133262.